Autori: Stojanovic Miroslav
| Naslov | Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial (Article) |
| Autori | Cohen Jeffrey ... Stojanovic Miroslav ... (broj koautora 18) |
| Info | LANCET, (2012), vol. 380 br. 9856, str. 1819-1828 |
| Projekat | Genzyme (Sanofi); Bayer Schering Pharma; Biogen Idec; Elan; Five Prime Therapeutics; Lilly; Novartis; Teva; Vaccinex; Waterfront Media; Genzyme; Merck Serono; Bayer; Coronado Biosciences; Consortium of Multiple Sclerosis Centers; Eli Lilly; EMD Serono; Ge |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Effect of Alemtuzumab vs. Rebif (R) on Brain MRI Measurements: Results of CARE-MS I, a Phase 3 Study (Meeting Abstract) |
| Autori | Arnold Douglas L Brinar Vesna Cohen Jeffrey Coles Alasdair Confavreux Christian Fisher Elizabeth Fox Edward Giovannoni Gavin Hartung Hans Havrdova Eva Selmaj Krzysztof Weiner Howard Stojanovic Miroslav Lake Stephen Margolin David Panzara Michael Compston Alastair |
| Info | NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Infections in Phase 3 Study: Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I) (Meeting Abstract) |
| Autori | Havrdova Eva Arnold Douglas L Cohen Jeffrey Coles Alasdair Confavreux Christian Fox Edward Hartung Hans Selmaj Krzysztof Weiner Howard Brinar Vesna Giovannoni Gavin Stojanovic Miroslav Lake Stephen Margolin David Oyuela Pedro Panzara Michael Compston Alastair |
| Info | NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Incidence of Autoimmunity in a Phase 3 Trial: Comparison of Alemtuzumab and Rebif (R) in Multiple Sclerosis I (CARE-MS I) (Meeting Abstract) |
| Autori | Selmaj Krzysztof Arnold Douglas L Brinar Vesna Cohen Jeffrey Coles Alasdair Confavreux Christian Fox Edward Giovannoni Gavin Hartung Hans Havrdova Eva Stojanovic Miroslav Weiner Howard Lake Stephen Margolin David Oyuela Pedro Panzara Michael Compston Alastair |
| Info | NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Relapse Outcomes with Alemtuzumab vs. Rebif (R) in Treatment-Naive Relapsing-Remitting Multiple Sclerosis (CARE-MS I): Secondary and Tertiary Endpoints (Meeting Abstract) |
| Autori | Fox Edward Arnold Douglas L Brinar Vesna Cohen Jeffrey Coles Alasdair Confavreux Christian Giovannoni Gavin Hartung Hans Havrdova Eva Selmaj Krzysztof Stojanovic Miroslav Weiner Howard Lake Stephen Margolin David Panzara Michael Compston Alastair |
| Info | NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients (Meeting Abstract) |
| Autori | Coles Alasdair Brinar Vesna Arnold Douglas L Cohen Jeffrey Confavreux Christian Fox Edward Hartung Hans Havrdova Eva Selmaj Krzysztof Weiner Howard Giovannoni Gavin Stojanovic Miroslav Lake Stephen Margolin David Panzara Michael Compston Alastair |
| Info | NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
